📊 NNOX Key Takeaways
Is NNOX a Good Investment? Thesis Analysis
Insufficient financial data available for fundamental analysis. With only 1 Form 4 filing in the last 90 days and no income statement, balance sheet, or cash flow metrics available, a comprehensive assessment of Nano-X's financial health, profitability, and growth trajectory cannot be performed. Additional SEC filings and current financial statements are required to evaluate investment merit.
Why Buy NNOX? Key Strengths
- Operates in specialized medical imaging sector (X-ray apparatus) with potential for innovation
- Listed on Nasdaq indicating meeting exchange listing standards
- Some insider activity detected suggesting ongoing management engagement
NNOX Investment Risks to Consider
- Critically limited financial disclosure - no revenue, profitability, or balance sheet data available
- Unable to assess liquidity, solvency, or cash burn rates
- No verifiable operating metrics to evaluate business traction or financial stability
- Extreme data scarcity prevents meaningful fundamental analysis
Key Metrics to Watch
- Latest 10-K or 10-Q filing with complete revenue and income statement data
- Cash position and burn rate relative to operating requirements
- Path to profitability and gross margin trends once commercial operations commence
NNOX Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
NNOX Profitability Ratios
NNOX vs Default Sector
How Nano-X Imaging Ltd. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is NNOX Overvalued or Undervalued?
Based on fundamental analysis, Nano-X Imaging Ltd. has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
NNOX Balance Sheet & Liquidity
NNOX Growth Metrics (YoY)
NNOX SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Nano-X Imaging Ltd. (CIK: 0001795251)
📋 Recent SEC Filings
❓ Frequently Asked Questions about NNOX
What is the AI rating for NNOX?
Nano-X Imaging Ltd. (NNOX) has an AI rating of HOLD with 15% confidence, based on fundamental analysis of SEC EDGAR filings.
What are NNOX's key strengths?
Claude: Operates in specialized medical imaging sector (X-ray apparatus) with potential for innovation. Listed on Nasdaq indicating meeting exchange listing standards.
What are the risks of investing in NNOX?
Claude: Critically limited financial disclosure - no revenue, profitability, or balance sheet data available. Unable to assess liquidity, solvency, or cash burn rates.
What is NNOX's revenue and growth?
Nano-X Imaging Ltd. reported revenue of N/A.
Does NNOX pay dividends?
Nano-X Imaging Ltd. does not currently pay dividends.
Where can I find NNOX SEC filings?
Official SEC filings for Nano-X Imaging Ltd. (CIK: 0001795251) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is NNOX's EPS?
Nano-X Imaging Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is NNOX a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Nano-X Imaging Ltd. has a HOLD rating with 15% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is NNOX stock overvalued or undervalued?
Valuation metrics for NNOX: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy NNOX stock in 2026?
Our dual AI analysis gives Nano-X Imaging Ltd. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is NNOX's free cash flow?
Nano-X Imaging Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does NNOX compare to other Default stocks?
Vs Default sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 1.8).